These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients. Malmberg H; Grahne B; Holopainen E; Binder E Clin Otolaryngol Allied Sci; 1983 Aug; 8(4):273-6. PubMed ID: 6228347 [TBL] [Abstract][Full Text] [Related]
7. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. Georgitis JW; Banov C; Boggs PB; Dockhorn R; Grossman J; Tinkelman D; Roszko P; Wood C Clin Exp Allergy; 1994 Nov; 24(11):1049-55. PubMed ID: 7874603 [TBL] [Abstract][Full Text] [Related]
8. Ipratropium treatment for rhinorrhoea in patients with perennial rhinitis. An open follow-up study of efficacy and safety. Schultz Larsen F; Mygind N; Larsen FS Clin Otolaryngol Allied Sci; 1983 Aug; 8(4):267-72. PubMed ID: 6228346 [TBL] [Abstract][Full Text] [Related]
9. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Dockhorn R; Aaronson D; Bronsky E; Chervinsky P; Cohen R; Ehtessabian R; Finn A; Grossman J; Howland W; Kaiser H; Pearlman D; Sublett J; Ratner P; Settipane G; Sim T; Storms W; Webb R; Drda K; Wood C Ann Allergy Asthma Immunol; 1999 Apr; 82(4):349-59. PubMed ID: 10227333 [TBL] [Abstract][Full Text] [Related]
10. Ipratropium in the treatment of patients with perennial rhinitis. Sjögren I; Juhász J Allergy; 1984 Aug; 39(6):457-61. PubMed ID: 6238545 [TBL] [Abstract][Full Text] [Related]
11. Intranasal ipratropium in the treatment of vasomotor rhinitis. Jokinen K; Sipilä P Rhinology; 1983 Dec; 21(4):341-5. PubMed ID: 6229864 [TBL] [Abstract][Full Text] [Related]
12. Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide. Dolovich J; Kennedy L; Vickerson F; Kazim F J Allergy Clin Immunol; 1987 Sep; 80(3 Pt 1):274-8. PubMed ID: 2957416 [TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy study of intranasal ipratropium bromide. Milford CA; Mugliston TA; Lund VJ; Mackay IS J Laryngol Otol; 1990 Feb; 104(2):123-5. PubMed ID: 2139094 [TBL] [Abstract][Full Text] [Related]
15. The effect of locally applied ipratropium aerosol on the nasal methacholine challenge in patients with allergic and non-allergic rhinitis. Sanwikarja S; Schmitz PI; Dieges PH Ann Allergy; 1986 Feb; 56(2):162-6. PubMed ID: 2936282 [TBL] [Abstract][Full Text] [Related]
16. Ipratropium treatment of rhinorrhea in perennial nonallergic rhinitis. A Nordic multicenter study. Kirkegaard J; Mygind N; Mølgaard F; Holopainen E; Malmberg H; Brøndbo K; Rojne T Acta Otolaryngol Suppl; 1988; 449():93-5. PubMed ID: 2974229 [No Abstract] [Full Text] [Related]
17. Ipratropium bromide in children with asthma. Mann NP; Hiller EJ Thorax; 1982 Jan; 37(1):72-4. PubMed ID: 6461943 [TBL] [Abstract][Full Text] [Related]
18. A trial of intranasal Atrovent versus placebo in the treatment of vasomotor rhinitis. Knight A; Kazim F; Salvatori VA Ann Allergy; 1986 Nov; 57(5):348-54. PubMed ID: 2946252 [TBL] [Abstract][Full Text] [Related]
19. Nasal methacholine challenge and ipratropium therapy. Laboratory studies and a clinical trial in perennial rhinitis. Borum P; Mygind N Acta Otorhinolaryngol Belg; 1979; 33(4):528-35. PubMed ID: 161465 [No Abstract] [Full Text] [Related]